Novo Nordisk to invest $158 million in insulin plant in Brazil
Danish drugmaker Novo Nordisk will invest $158.2 million to modernise a plant in Brazil responsible for pumping a quarter of its global insulin production. The funds will be used to modernise the Montes Claros factory in the state of Minas Gerais and implement sustainable projects there.
BELIEBTE BEITRÄGE
IEA warns ‘electricity era’ will come after fossil fuels peak
Oktober 17, 2024
Easter Island fights global plastic waste vortex
Oktober 17, 2024
Egypt opens more galleries at its antiquities museum
Oktober 17, 2024
LIVEÜBERTRAGUNG